KAND567 Versus Placebo in Subjects Hospitalized With COVID-19
Clinical trial NCT06012565 · TERMINATED
Trial details
- NCT number
- NCT06012565
- Sponsor
- Novakand Pharma AB
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-11
- Primary completion
- 2021-08-07
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.